Tatva Chintan Pharma Chem Q2 Results FY27: PAT Jumps 116.23%, Revenue Rs 217.32 Cr, PAT Rs 21.45 Cr
- October 19, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Tatva Chintan Pharma Chem Q2 Results FY27 were declared on 19 October 2026 as consolidated quarterly results for the July to September 2026 period. Revenue rose 75.94% YoY to Rs 217.32 Cr, while net profit increased 116.23% YoY to Rs 21.45 Cr. The results date, YoY growth and consolidated results together show a stronger reported quarter, with Operating Profit also up 83.12%.
Tatva Chintan Pharma Chem Ltd (TATVA) Q2 Results FY27 announced on 19 October 2026, covering the company’s financial performance for the July to September 2026 quarter. Tatva Chintan Pharma Chem Q2 Results FY27 showed consolidated revenue of Rs 217.32 Cr versus Rs 123.52 Cr a year earlier, while net profit rose to Rs 21.45 Cr from Rs 9.92 Cr. The results date and consolidated results basis frame the reported numbers clearly.
Tatva Chintan Pharma Chem Q2 Results present a results analysis built around revenue, the Operating Profit line and net profit, all of which improved on a YoY basis. For investors tracking the chemicals space, the numbers offer a clean reference point for financial highlights, business drivers, outlook and risks, which are covered below in a structured Univest analysis before the table.
Click Here – Get Free Investment Predictions
Tatva Chintan Pharma Chem Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 217.32 Cr | Rs 123.52 Cr | +75.94% YoY |
| Operating Profit | Rs 40.69 Cr | Rs 22.22 Cr | +83.12% YoY |
| Net Profit (PAT) | Rs 21.45 Cr | Rs 9.92 Cr | +116.23% YoY |
Source: company filing for Tatva Chintan Pharma Chem Q2 Results FY27, 19 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Tatva Chintan Pharma Chem Q2 Results: What Stands Out
- Revenue: Rs 217.32 Cr, up 75.94% YoY, which is the clearest headline in Tatva Chintan Pharma Chem Q2 Results FY27.
- Net profit: Rs 21.45 Cr, up 116.23% YoY, showing stronger net profit conversion in the quarter.
- Operating Profit: Rs 40.69 Cr, up 83.12% YoY, which tracked the rise in revenue and net profit.
- Quarterly results pattern: Tatva Chintan Pharma Chem Q2 Results FY27 continue the four-quarter revenue rise noted in the disclosed business factors.
- What to watch: The next results analysis will focus on whether revenue and net profit sustain this YoY growth trend.
Tatva Chintan Pharma Chem Q2 Results FY27: Performance Analysis
Tatva Chintan Pharma Chem Q2 Results FY27 show a quarter where revenue, Operating Profit and net profit all expanded sharply on a YoY basis. The consolidated results for Q2 FY27 reported Rs 217.32 Cr in revenue and Rs 21.45 Cr in net profit, while Operating Profit came in at Rs 40.69 Cr. That is the core results analysis investors should note first.
The same quarterly results also show that revenue grew 75.94% and net profit rose 116.23% against the same quarter last year. Tatva Chintan Pharma Chem Q2 Results FY27 therefore point to a broad-based improvement in reported numbers rather than movement in only one line. The next Univest review point is how the disclosed business factors shaped this trend and what it means for subsequent quarters.
From a results analysis perspective, the quarter is best read as a strong reported period with all major disclosed figures moving in the same direction. Tatva Chintan Pharma Chem Q2 Results FY27 now hand over to the business factors, where the reported quarterly results should be read alongside the company-specific drivers already disclosed.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue growth – Revenue grew 75.9% year on year to Rs 217.32 Cr in the latest quarter. That remains the most direct explanation in the disclosed quarterly results and it sets the base for the rest of the analysis.
Net profit expansion – Net profit rose 116.2% year on year to Rs 21.45 Cr. The business factor disclosure also notes that net profit margin improved to 9.9% from 8.0% in the comparison quarter, which supports the reported improvement.
Operating momentum – Revenue has risen in each of the last 4 quarters. In Tatva Chintan Pharma Chem Q2 Results FY27, that run of growth is the clearest company-specific context provided for the quarter’s financial performance and quarterly results.
FY27 Outlook After Tatva Chintan Pharma Chem Q2 Results
The FY27 outlook after Tatva Chintan Pharma Chem Q2 Results is best read through the disclosed numbers and the next set of filings, because no separate management guidance has been supplied here. This results analysis shows strong net profit and revenue growth, but the full-year picture will still depend on subsequent quarters and the disclosed sector environment.
For now, the quarter leaves investors with a simple factual base: consolidated results improved materially, and net profit moved ahead faster than revenue in YoY terms. Tatva Chintan Pharma Chem Q2 Results FY27 therefore serve as one quarter within the broader FY27 cycle, and the next results analysis should focus on whether the reported trajectory continues in the coming quarters.
Key Risks to Watch After Tatva Chintan Pharma Chem Q2 Results FY27
Return on equity
Return on equity was low at 5.53% in FY26. That figure matters in any results analysis because it frames how efficiently the company has converted reported earnings into shareholder returns, even after the latest YoY growth.
Return on capital employed
Return on capital employed was modest at 7.17% in FY26. Investors tracking Tatva Chintan Pharma Chem Q2 Results FY27 should keep this in view alongside the quarterly results and the company’s reported profit progression.
Profit volatility
Quarterly net profit has been volatile, ranging from Rs 9.92 Cr to Rs 21.45 Cr over the last 5 quarters. That range is part of the disclosed risk set and should be read together with YoY growth trends, not in isolation.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Tatva Chintan Pharma Chem Q2 Results FY27 were a consolidated quarterly results update with revenue of Rs 217.32 Cr and net profit of Rs 21.45 Cr, both higher on a YoY basis. The reported figures and the Operating Profit line support a clear results analysis, but investors should still read the quarter within the broader consolidated results trend and consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Tatva Chintan Pharma Chem Q2 Results FY27
What are Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 are the company’s consolidated quarterly results for July to September 2026, with revenue of Rs 217.32 Cr and net profit of Rs 21.45 Cr.
What is the results date for Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 were announced on 19 October 2026, which is the disclosed results date. That date also anchors the consolidated results and the opening summary in this article.
What revenue was reported in Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 reported revenue of Rs 217.32 Cr. Compared with Rs 123.52 Cr in the same quarter last year, the Financial Highlights table shows 75.94% YoY growth.
What net profit was reported in Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 reported net profit of Rs 21.45 Cr. That is higher than Rs 9.92 Cr in the year-ago quarter, as discussed in the Key Takeaways and Performance Analysis sections.
How much YoY growth did revenue show in Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 showed 75.94% YoY growth in revenue. This came from Rs 217.32 Cr versus Rs 123.52 Cr a year earlier, as captured in the Financial Highlights table.
Did net profit rise or fall in Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 saw net profit rise to Rs 21.45 Cr from Rs 9.92 Cr. That equals 116.23% YoY growth, which is explained in the Performance Analysis section.
What was the Operating Profit in Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 reported Operating Profit of Rs 40.69 Cr. The same line stood at Rs 22.22 Cr in the year-ago quarter, showing 83.12% YoY growth in the Financial Highlights table.
Are Tatva Chintan Pharma Chem Q2 Results FY27 consolidated results or standalone results?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 are consolidated results. That basis is stated in the results announcement and repeated throughout the article for consistency.
What business factors shaped Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 were shaped by revenue growth to Rs 217.32 Cr, higher net profit and an improved net profit margin.
What are the key risks after Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 still carry risks linked to modest return ratios and profit volatility. The Key Risks section highlights FY26 ROE of 5.53%, ROCE of 7.17% and quarterly net profit swings.
What is the outlook after Tatva Chintan Pharma Chem Q2 Results FY27?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 leave the FY27 outlook dependent on subsequent quarters and disclosed operating conditions. The Outlook section explains that net profit strength is visible, but full-year results will depend on future filings.
Where can I find the complete Tatva Chintan Pharma Chem Q2 Results FY27 data?
Ans. Tatva Chintan Pharma Chem Q2 Results FY27 data is covered in this article’s Quick Answer, Financial Highlights and Performance Analysis sections. Those sections together present the revenue, net profit and Operating Profit figures in one place.
